04.06.2020 Novavax Inc Daily Analysis

04.06.2020 Novavax Inc Daily Analysis

Novavax Inc (NVAX) 44.25usd, -5.39,-10.86% Today Novavax is trading at 44.25usd, the stock dropped with almost 11 percent. Novavax is one of the leading companies in the race to develop a vaccine for COVID-19. The company recently announced the initiation of a phase 1/2 clinical trial to investigate the efficacy of its potential vaccine for COVID-19 -- NVX-CoV2373. Phase 1 part of this trial which is going to be conducted in Australia, will enroll 130 healthy adult volunteers and will test the vaccine's safety and its immunogenicity. Investors have high hopes for Novavax's NVAX-CoV2373. The reason why the stock was going down was caused by what Dr. Anthony Fauci said in an interview with JAMA where he outlined a potential vaccine for COVID-19    will not be able to provide long-term immunity.